The Biggest Health Care Reform in a Decade Could Lower Your Costs
Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act in The New York Times op-ed, “The Biggest […]
Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act in The New York Times op-ed, “The Biggest […]
This slideshow explains the prescription drug provisions proposed in the Inflation Reduction Act as passed by the Senate
As part of the Inflation Reduction Act, the Senate recently passed a three-year extension (through 2025) of enhanced subsidies for people buying their own health […]
The House is expected to take up the Senate-passed Inflation Reduction Act later this week, a sweeping bill that includes several landmark health care provisions […]
Congress is considering an extension of extra help for people buying their own health coverage on the Affordable Care Act Marketplaces. This post highlights key […]
This analysis finds that the ACA’s maximum out-of-pocket limit is likely to grow faster than wages and salaries, and is also expected to grow faster […]
This analysis of marketplace insurers’ early rate filings in 13 states and the District of Columbia finds that they are seeking higher premium increases than […]
A new KFF analysis of marketplace insurers’ early rate filings in 13 states and the District of Columbia finds that they are seeking higher premium […]
The health care costs associated with pregnancy and childbirth average almost $19,000, including $2,854 paid out-of-pocket, a new KFF analysis of large employers’ insurance claims […]
This analysis looks at the health care costs associated with pregnancy, including prenatal care, childbirth, and postpartum care. It finds women who give birth incur […]
The KFF Health Care Debt Survey finds that four in ten adults have some form of health care debt, with most citing one-time or short-term […]
Prices for medical services typically rise more quickly than the broader economy, but the reverse has been true recently as general inflation rose rapidly. The […]
We find that insurers estimate they will issue a total of about $1 billion in Medical Loss Ratio (MLR) rebates this year across all commercial […]
Private insurance companies are expecting to pay out $1 billion in rebates to consumers this fall under an Affordable Care Act provision that requires insurers […]
We review several policy options to constrain health care spending, primarily by putting downward pressure on provider prices, including price regulation, global budgets, and spending […]
U.S. prescription drug spending per person is about double what it is in peer countries and about 8 in 10 U.S. adults say the cost […]
In this column for the JAMA Health Forum, Larry Levitt highlights four changes implemented during the COVID-19 pandemic that helped to make health care more […]
Most customers with coverage through Affordable Care Act’s marketplaces will face big premium increases next year if Congress doesn’t extend the temporary enhanced tax credits […]
A new KFF interactive provides essential facts and trends about spending on Medicare, the federal health insurance program that covers 65 million seniors and people […]
Against the backdrop of public concern about inflation and rising gas prices, proposals to lower what people pay out-of-pocket for drugs tops the public’s list […]
A new federal law provides new consumer protections against “surprise” medical bills beginning this year. Test your knowledge about its provisions with this 12-question quiz.
In the face of rising prescription drug costs, a large majority of the public supports federal efforts to lower drug spending. Policymakers are considering several […]
A new analysis from KFF and Epic Research finds that telehealth visits for outpatient mental health and substance use services went from virtually zero percent […]
This analysis from KFF and Epic Research finds that telehealth visits for outpatient mental health and substance use services went from virtually zero percent in […]
Americans Likely Owe Hundreds of Billions of Dollars in Total Medical Debt A new KFF analysis of government data estimates that nearly 1 in 10 […]
This analysis uses government data to examine the burden of medical debt, including variations based on age, race and ethnicity, and health status . It […]
This analysis looks at the share of working families’ income that is spent on premiums, deductibles and other cost-sharing for employer-sponsored care. It shows that […]
This analysis assesses whether people can afford to pay cost-sharing amounts common with private insurance plans. It finds that large shares of non-elderly households do […]
The Vaccine Monitor report examines how families and workers fared financially during the omicron surge. Large shares of workers missed work due to being sick […]
The surge in COVID-19 cases triggered by the omicron variant led to widespread work disruptions, with about 4 in 10 workers (42%) – including 6 […]
Recent legislation would require drug companies to pay rebates to the federal government when annual increases in prescription drug prices for Medicare and private insurance […]
This slideshow examines trends in U.S. health spending over time, including the share of household budgets devoted to health expenses and comparisons of out-of-pocket expenditures […]
This updated analysis examines COVID-19’s effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes […]
This chart collection examines what we know about prescription drug spending and use in the U.S. and comparably large and wealthy countries, using data from […]
This updated analysis examines COVID-19’s effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes […]
This Health Affairs Grantwatch article summarizes findings from several KFF-Peterson Health System Tracker analyses with an emphasis on the COVID-19 pandemic’s impact through 2021 and […]
This chart collection compares health care spending in the U.S. and other industrialized countries, including data on health spending per person and the growth rate […]
This policy watch provides an early look at how top private insurers are implementing a new requirement to cover the cost of at-home COVID-19 tests. […]
In this column for the JAMA Health Forum, Larry Levitt examines how the No Surprises Act that prohibits unexpected out-of-network charges for patients could lead […]
In this commentary for Barron’s, Cynthia Cox and Lindsey Dawson examine the cost and availability of at-home COVID-19 tests and how the new Biden administration policy […]
This slideshow examines how cost and insurance affects people’s access to care, including decisions to forgo or delay needed care and access to a usual […]
In a new Policy Watch, KFF experts explain why Medicare’s preliminary decision to cover a new Alzheimer’s drug only for a limited group of beneficiaries […]
New 2020 data on U.S. health spending are now available on the Health Spending Explorer, an interactive tool that allows users to explore trends in […]
This brief summarizes KFF’s most recent polling on the public’s experiences and challenges with health care costs, and it highlights the consequences of high health […]
Unlike past recessions, the health sector saw a big drop in employment in early 2020 similar to other sectors as the COVID-19 pandemic shut down […]
This chart collection takes a deep dive into employment data to analyze how jobs and wages in the health sector shrank and recovered during the […]
The “No Surprises Act,” which establishes new federal protections against most surprise out-of-network medical bills when a patient receives out-of-network services during an emergency visit […]
This slideshow explains the latest prescription drug provisions in the Build Back Better Act (BBBA).
Premiums for the Affordable Care Act Marketplace benchmark silver plan are decreasing 3.1 percent on average across the country – the fourth year in a […]
Premiums for ACA Marketplace benchmark silver plans are decreasing on average across the U.S. in 2022. However, premium changes vary widely by location and by […]
Wednesday, December 8, 2021 at 9:00 a.m. PT/12:00 p.m. ET As the Build Back Better Act shifts from the House to the Senate, there’s considerable […]
Wednesday, December 8, 2021 at 9:00 a.m. PT/12:00 p.m. ET As the Build Back Better Act shifts from the House to the Senate, there’s considerable […]
As the House-passed Build Back Better Act moves to the Senate, a new explainer from KFF summarizes the key prescription drug provisions within the broader […]
This slideshow explores the variation in health spending across the population through an analysis of the 2019 Medical Expenditure Panel Survey (MEPS) data. It finds […]
This graphing tool allows users to explore trends in workplace-sponsored health insurance premiums and worker contributions over time for different categories of employers based on […]
This slideshow captures key data from the 2021 KFF Employer Health Benefits Survey survey, providing a detailed look at trends in employer-sponsored health coverage, including […]
This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. […]
Annual family premiums for employer-sponsored health insurance rose 4% to average $22,221 this year, according to the 2021 benchmark KFF Employer Health Benefits Survey released […]
KFF will release its 2021 benchmark Employer Health Benefits Survey via a public web briefing on Wednesday, Nov. 10 at 1 p.m. ET. This 23rd […]
A summary of 10 of the major health coverage and financing provisions of the original Build Back Better Act, with discussion of the potential implications […]
This updated analysis finds that in September 2021, COVID-19 ranked as the 2nd leading causes of death in the U.S., up from 8th in July, […]
This data note from the latest KFF Health Tracking Poll explores the public’s views on Medicare drug price negotiation, including how arguments on both sides […]
Most of the Public Lacks Confidence that President Biden, Congressional Democrats or Republicans Will Do the Right Thing on Drug Prices Allowing the federal government […]
This slideshow compares life expectancy in the U.S. and other nations. The data shows that life expectancy at birth is lower in the U.S. than […]
In a new Policy Watch, KFF analysts explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new […]
In this Policy Watch we explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new eligibility for […]
Many Medicare beneficiaries face high annual out-of-pocket costs for dental and hearing care — services that generally aren’t covered in traditional Medicare, but typically are […]
This analysis builds on our prior work – Medicare and Dental Coverage: A Closer Look – by analyzing hearing and vision use, out-of-pocket spending and […]
In this commentary for Barron’s, Cynthia Cox explores the impact to the American public as the U.S. health insurance system adjusts to the COVID-19 pandemic. She […]
With the rapid uptake in vaccinations in recent months, COVID-19 deaths have fallen sharply. COVID-19 is now the seventh leading cause of death in the […]
This Peterson-KFF Health System Tracker analysis finds that over 100,000 COVID-19 hospitalizations could have been prevented with adult vaccination in June and July of this year, […]
This analysis finds nearly three quarters of the largest health plans in each state are no longer waiving enrollees’ cost-sharing requirements for COVID-19 treatment as […]
This analysis finds hospital admissions remained below expected levels in early 2021, suggesting much of the care people put off during the early months of […]
These FAQs discuss recent efforts related to prescription drug importation, the history of this approach, challenges that previous efforts to carry out importation proposals have […]
In this Axios column, Drew Altman unpacks President Biden’s recent executive order on promoting competition, exploring its significance for new efforts to control health costs […]
After a tumultuous year of unpredictable COVID-19 changes to utilization and spending, a review of early rate filings for individual market insurers participating in the […]
This brief reviews initial 2022 premium rate filings for Marketplace-participating individual market insurers in 13 states and the District of Columbia. Most expect health utilization […]
The brief examines the potential impact of Aduhelm, a newly approved drug for Alzheimer’s disease, on state and federal Medicaid costs and looks at potential […]
With the rapid uptake in vaccinations in recent months, COVID-19 deaths have fallen sharply. COVID-19 is now the seventh leading cause of death in the […]
This charticle draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include […]
The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people […]
With increased attention to the global need for COVID-19 vaccines and the Biden administration’s announcement today about how it plans to distribute the first portion […]
The latest KFF Health Tracking Poll explores the public’s views on the U.S. role in distributing COVID vaccines to other countries, health care priorities for […]
In this column for the JAMA Health Forum, Larry Levitt examines the implications of lowering Medicare’s age of eligibility, which is emerging as a potential […]
Although attention in current federal actions is largely focused on Medicare and private insurance drug prices, federal legislation also has been recently introduced or enacted […]
A new KFF analysis shows that lowering the age of Medicare eligibility to 60 could improve the affordability of coverage for people who are already […]
This analysis examines insurers’ financial data across markets through the end of 2020. It finds that average margins remained relatively high compared to recent years, […]
This survey of executive decision-makers at over 300 large private employers finds most see rising health costs as a threat to their businesses and believe […]
Top executives at nearly 90% of large employers surveyed believe the cost of providing health benefits to employees will become unsustainable in the next five-to-10 […]
In this Axios column, Drew Altman explores whether the long struggle with rising health costs has caused the tide to turn in corporate leaders’ attitudes […]
Two new KFF analyses find that lowering the age of Medicare eligibility from 65 to 60 could significantly reduce health spending for employers, who could […]
During the presidential campaign, President Biden proposed to lower the age of Medicare eligibility from 65 to 60. This analysis uses claims data for covered […]
This analysis for the Peterson-KFF Health System Tracker illustrates the potential for employer savings if the age of Medicare eligibility were lowered to 60, as […]
The COVID-19 pandemic and recent elections are changing the national conversation around expanding health care coverage and reining in rising health care costs. President Biden […]
A new KFF analysis finds that a relatively small share of drugs, mainly those without generic or biosimilar competitors, accounted for a disproportionate share of […]
As policymakers focus attention on proposals to lower prescription drug costs by allowing price negotiation or international reference pricing for a limited number of drugs, […]
In spite of a new price transparency rule that requires hospitals to publish the prices of common health services, comparing prices across hospitals remains challenging […]
A new issue brief examines compliance with a new federal price transparency rule and variation in payer-negotiated rates at U.S. hospitals. The analysis looks at […]
A new issue brief reviews excess death rates in the U.S. and peer countries by age groups to examine how the pandemic has affected excess […]
A new KFF issue brief examines 2020 data on excess mortality – the number of deaths above what is expected in a typical year – […]
This brief examines how the CMS Innovation Center (also known as CMMI) and Section 402 demonstration authority could become pathways for the Biden Administration to […]
Majorities Favor Provisions to Expand Marketplace Tax Credits and Encourage States to Expand Medicaid As Congress considers an additional $1.9 trillion COVID-19 relief plan, more […]
This poll examines the public’s assessments of the Biden administration’s handling of the coronavirus pandemic, the impact COVID-19 has had on people’s finances, and support […]
Total health care spending for people with private health insurance would be an estimated $352 billion lower in 2021 if private insurers used Medicare rates […]
This analysis estimates the total annual reduction in health care spending by employers and privately insured individuals that would result from having private insurers reimburse […]
This summarizes key provisions of the No Surprises Act, enacted in December 2020 to address the problem of unexpected medical bills, and issues that could […]
A new issue brief examines the most recent data on deaths from COVID-19 and other causes, and finds that COVID-19 is currently the number one […]
Published in the Jan. 19 edition of JAMA, this article from KFF Executive Vice President for Health Policy Larry Levitt lays out the major health […]
A new KFF analysis examines how new federal rules on price transparency for health services may affect patient decision-making and market pricing. As of January […]
A new Peterson-KFF analysis examines the potential impact of new federal price transparency rules on patient decision-making and market pricing for health services. The brief […]
In this column for the JAMA Health Forum, Larry Levitt explores what President-elect Biden might do to advance his health care vision both through legislation […]
As the first doses of the new COVID-19 vaccine are delivered to health care workers and other early recipients, many Americans are eager to know […]
In the issue brief, KFF experts highlight the laws and regulations that are in place to ensure access to free COVID-19 vaccines for individuals regardless […]
As winter sets in and COVID-19 cases and deaths reach records in most parts of the country, more Americans say they wear masks every time […]
The Health Spending Explorer on the Peterson-KFF Health System Tracker helps users examine five decades worth of numbers documenting expenditures by federal and local governments, […]
In this brief, we analyze third quarter data from 2018 to 2020 to examine how insurance markets performed financially through the end of September. Average […]
A new chart collection looks at how internet access may affect health care in the U.S., as more providers turn to telemedicine during the pandemic. […]
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.
This chart collection summarizes what is known so far about how health costs and utilization have changed during the COVID-19 pandemic. Health spending is on […]
New analysis from Drew Altman in his latest Axios column on the impact of the coronavirus pandemic on national health spending.
The brief provides an overview of how vaccines are reimbursed and covered across government programs and different types of health insurance in the United States. […]
A new chart collection examines what we know about the cost of common health services in the U.S. The analysis shows that costs for many […]
This interactive map shows the status of all Section 1332 waivers requested by states. The Affordable Care Act (ACA) allows states to apply for innovation […]
This brief describes health insurance subsidies available through the Affordable Care Act’s marketplaces, including premium subsidies that would be provided in the form of tax […]
A new KFF analysis examines leading causes of death and mortality rates in the United States and comparable countries. The U.S. has a higher COVID-19 […]
A new KFF brief looks at where COVID-19 falls as a leading cause of death in the U.S. compared to similarly large and wealthy countries. […]
In this perspective published by the Washington Post, KFF Executive Vice President for Health Policy Larry Levitt explains why the popular Affordable Care Act provisions […]
As the 2020 Election Day approaches, many candidates continue to focus on health care issues, including on the public health and economic response to COVID-19, […]
In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the […]
This brief analyzes hospital admission data to show how the number of admissions changed in 2020 due to the COVID-19 pandemic.
The poll examines the public’s views on the Supreme Court case to overturn the Affordable Care Act and its protections for people with pre-existing conditions. […]
U.S. Supreme Court decisions shape health policy in important ways. The nomination of Judge Amy Coney Barrett, if confirmed, is expected to establish a solid […]
This slideshow captures key data from the 2020 KFF Employer Health Benefits Survey survey, providing a detailed look at trends in employer-sponsored health coverage, including […]
This graphing tool allows users to explore trends in workplace-sponsored health insurance premiums and worker contributions over time for different categories of employers based on […]
San Francisco – Annual family premiums for employer-sponsored health insurance rose 4% to average $21,342 this year, according to the 2020 benchmark KFF Employer Health […]
This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, offer rates, wellness programs, […]
This slideshow explains the similarities and differences among major proposals to lower prescription drug costs introduced by the Trump Administration, members of Congress, and the […]
This side-by-side comparison examines President Trump’s record and former Vice President Biden’s positions across a wide range of key health issues, including the response to […]
A new issue brief examines the role of the Veterans Health Administration (VHA) during the coronavirus pandemic, and public health emergencies more broadly. The analysis […]
This brief reviews what we know about the impact of provider consolidation on health care prices and quality and finds that consolidation leads to higher […]
In this Axios column, Drew Altman looks at how the heroic performance of the nation’s doctors on the frontlines of coronavirus care and effective communication […]
This brief survey examines how the public views the motivations of doctors, nurses, insurance companies, and drug companies when it comes to making profits vs. […]
Newly updated and expanded, the Peterson-KFF Health System Dashboard compiles data on the U.S. health system’s performance in four areas: access and affordability, health and well-being, health […]
The Peterson-KFF Health System Dashboard examines the U.S. health system’s performance in four areas: access and affordability, health and well-being, health spending, and quality of […]
This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal […]
A new KFF analysis of what large hospitals nationwide charge for out-of-network COVID-19 tests show a wide range of publicly posted prices — from $20 […]
Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 32 states that have eased or lifted stay-at-home […]
The COVID-19 pandemic and resulting economic downturn are taking a toll on mental health for many Americans, with large shares of the public saying that […]
This chart collection compares the quality of health care in the United States to that in other wealthy and sizable countries. While all have seen […]
This issue brief analyzes hospital payments paid by private payers and by Medicare for a selection of inpatient services, including services requiring similar inpatient treatments […]
Copyright © 2024 | WordPress Theme by MH Themes